Have a feature idea you'd love to see implemented?
Let us know!
TTOO T2 Biosystems Inc
Price (delayed)
$0.4258
Market cap
$8.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.27
Enterprise value
$25.27M
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster
Highlights
The EPS has soared by 99% YoY and by 69% from the previous quarter
The debt has plunged by 62% YoY
TTOO's equity has dropped by 99% since the previous quarter but it is up by 39% year-on-year
T2 Biosystems's gross margin has shrunk by 55% YoY but it has increased by 12% QoQ
T2 Biosystems's quick ratio has shrunk by 60% YoY and by 32% QoQ
Key stats
What are the main financial stats of TTOO
Market
Valuations
Earnings
Shares outstanding
21.04M
Market cap
$8.96M
Enterprise value
$25.27M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.29
Revenue
$7.68M
EBIT
-$39.77M
EBITDA
-$38.03M
Free cash flow
-$36.62M
Per share
Balance sheet
Liquidity
EPS
-$1.27
Free cash flow per share
-$2.05
Book value per share
-$0.67
Revenue per share
$0.43
TBVPS
$1.01
Total assets
$18.08M
Total liabilities
$29.79M
Debt
$18.94M
Equity
-$11.71M
Working capital
-$14.65M
Debt to equity
-1.62
Current ratio
0.4
Quick ratio
0.19
Net debt/EBITDA
-0.43
Margins
Efficiency
Dividend
EBITDA margin
-495.3%
Gross margin
-76.8%
Net margin
-559.5%
Operating margin
-542.6%
Return on assets
-172.9%
Return on equity
N/A
Return on invested capital
-335.3%
Return on capital employed
N/A
Return on sales
-518%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TTOO stock price
How has the T2 Biosystems stock price performed over time
Intraday
-7.8%
1 week
-18.12%
1 month
-70.22%
1 year
-88.79%
YTD
-93.22%
QTD
-78.39%
Financial performance
How have T2 Biosystems's revenue and profit performed over time
Revenue
$7.68M
Gross profit
-$5.89M
Operating income
-$41.66M
Net income
-$42.95M
Gross margin
-76.8%
Net margin
-559.5%
T2 Biosystems's gross margin has shrunk by 55% YoY but it has increased by 12% QoQ
The revenue has decreased by 30% YoY but it has increased by 7% from the previous quarter
The net margin has decreased by 23% YoY but it has increased by 17% from the previous quarter
TTOO's operating margin is down by 20% year-on-year but it is up by 14% since the previous quarter
Growth
What is T2 Biosystems's growth rate over time
Valuation
What is T2 Biosystems stock price valuation
P/E
N/A
P/B
N/A
P/S
0.99
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.29
The EPS has soared by 99% YoY and by 69% from the previous quarter
TTOO's equity has dropped by 99% since the previous quarter but it is up by 39% year-on-year
The P/S is 82% below the 5-year quarterly average of 5.6 and 80% below the last 4 quarters average of 4.9
The revenue has decreased by 30% YoY but it has increased by 7% from the previous quarter
Efficiency
How efficient is T2 Biosystems business performance
The ROS has contracted by 29% YoY but it has grown by 16% from the previous quarter
The ROA has contracted by 28% YoY and by 12% from the previous quarter
The ROIC has grown by 6% from the previous quarter
Dividends
What is TTOO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TTOO.
Financial health
How did T2 Biosystems financials performed over time
TTOO's total assets is 39% less than its total liabilities
T2 Biosystems's quick ratio has shrunk by 60% YoY and by 32% QoQ
TTOO's total assets has plunged by 58% YoY and by 17% from the previous quarter
TTOO's equity has dropped by 99% since the previous quarter but it is up by 39% year-on-year
The debt has plunged by 62% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.